Alpine Global Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-11,317
Closed -$507K 223
2024
Q2
$507K Buy
+11,317
New +$507K 0.09% 175